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1. Introduction 
Oxytocin as a hormonal imprinter: Oxytocin is a mammalian neurohypophysial 
hormone, which was discovered by British pharmacologist Sir Henry Dale in 1906. 
Oxytocin is produced in the paraventricular nuclei of the hypothalamus and stored in the 
posterior part of the neurohypophysis, but also in neurons projecting from the 
paraventricular nucleus and surrounding structures to extra hypothalamic brain areas (i.e., 
the septum, the ventral tegmental area, the hippocampus, the amygdala, the medulla 
oblongata and the spinal cord). Oxytocin has role in various behaviors, including numerous 
central functions such as sexual, maternal behaviour, social recognition, anxiety, memory, 
learning, stress and social behaviors. Most of oxytocin’s roles are due to the cooperation 
with biogenic amines in different brain region. It has emerged that disturbance in 
peripheral and central oxytocin levels have been detected in some patients with dopamine 
dependent disorders. Thus, oxytocin is proposed to be a key neural substrate that interacts 
with central dopamine systems. Stress induced increases in sympathoadrenal release of 
adrenaline and noradrenaline, which increases heart and respiratory rate. Oxytocin 
administered cause reduce the rate and force of cardiac cells intrinsic contractions causing 
them to beat more slowly and contract less forcefully therefore the connection between the 
catecholamines and oxytocin was always important. Serotonin effect on the mood is 
through its association with influence on the release of oxytocin. Stimulation of the 
hypothalamus by serotonin has been shown to lead to release of oxytocin.  
Investigation of biogenic amines roles in the mechanism of drug action, their relation with 
oxytocin, their relations with the developing hormone receptors (hormonal imprinting), 
and their possible alteration in neuropsychiatric disorders all require an accurate 
determination of biogenic amines.  
Hormonal imprinting is a basic biological phenomenon, which was first observed, named, 
and defined in 1980 by Csaba. The phenomenon means that in the developmentally critical 
periods, animals or their cells memorize normally or pathologically this first encounter 
with a given hormone or related structures, and this determines the receptor’s later binding 
capacity as well as the reaction of the imprinted cell to the hormone for life. 
The present study is concerned with the effect of oxytocin on the biogenic amine levels of 
the adult rat brain.
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K-203 as an acetylcholinesterase reactivator: Organophosphates (OPs) are widely used 
all over the world in agriculture (pesticides, insecticides, acaricides) and in chemical 
industry (softeners, additives to lubricants). In the terrorist attack were used as an 
organophosphate warfare agents at Tokyo metro station and during the Iraq-Iran war, 
therefore organophosphate poisoning is a constant danger in the agriculture, giving 
hundred thousands of fatal cases in each year.  
Organophosphates are esters, amides or thiol derivatives of phosphoric, phosphonic, 
phosphinic acids, and phosphorothioic or phosphonothioic acid. The phosphonic acids 
derivatives are more toxic than the phosphinic acids. They are very lipophilic agents and 
acute exposure results in acute cholinergic crisis at muscarinic and nicotinic acetylcholine 
receptors (AChR) both in the central and the peripheral nervous systems. 
Organophosphates cause irreversible inhibition of cholinesterases via a covalent reaction 
with the serine in the active center of the enzyme. The therapy is known by the acronym 
“AFLOP” (atropine, fluid, oxygen and pralidoxime). 
Pyridinium aldoximes such as pralidoxime and obidoxime are the only clinically available 
acetylcholinesterase enzyme reactivators (AChERs) applied to organophoshates poisoned 
persons. In the Department of Toxicology at the Faculty of Military Health Sciences, 
Defence University, Hradec Kralove, Czech Republic more than 500 asymmetric 
pyridinium aldoxime compounds (K-compounds, kukoximes) were synthesized. Following 
preliminary toxicological and in vitro effectiveness studies some of them were show to be 
used as acetylcholinesterase reactivators for the treatment of intoxication following 
exposure to tabun, soman and certain organophosphate pesticides. Oximes are well known 
to reactivate the inhibited/phosphylated acetylcholinesterase but after so many years of the 
discovery, no oximes found to be a broad spectrum and effective against different groups 
of organophosphorus anticholinesterases therefore requesting more investigation. The 
present study is concerned with the effect of K-compounds on the biogenic amine levels of 
the adult rat brain but for the better understanding AChE, organophosphorus compounds 
and oximes are being discussed here.  
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2. Aims and objectives 
2.1. Optimize a sensitive bioanalytical method for determination of the biogenic amines 
and their metabolites by High Performance Liquid Chromatography electrochemical 
detection (HPLC-EC) 
 
2.2. Determine the possible hormonal imprinting effect of oxytocin on the biogenic amine 
and their metabolite levels of the adult rat brain 
 
2.3. Determine the effect of K-203 (AChERs), as a potential antidote in OPs intoxication 
on the biogenic amine and their metabolite levels of the adult rat brain 
 
3. Materials and Methodes 
3.1. Materials 
Oxytocin acetate salt hydrate, dopamine hydrochloride, DOPAC (3-4-
dihydroxyphenylacetic acid), homovanillic acid  (HVA), serotonin hydrochloride (5-HT), 
5-hydroxy-3-indole acetic acid (5-HIAA), 5-hydroxytriptophol (5-HTOL), phosphoric acid 
(H3PO4), disodium hydrogen phosphate dihydrate (Na2HPO4·12H2O), citric acid 
monohydrate, l-octane sulfonic acid sodium salt and Na2EDTA were from Sigma-Aldrich 
(Steinheim, Germany). Acetonitrile was from Merck (Darmstadt, Germany) and perchloric 
acid 70% (PCA) was from Fluka (Buchs, Switzerland). K-203 (E-1-(4-
carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide) was 
synthesized and kindly donated by K. Kuca (Department of Toxicology, Faculty of 
Military Health Sciences, Defence University, Hradec Kralove, Czech Republic). 
Samples were analyzed by reversed phase high-performance liquid chromatography with 
amperometric/electrochemical detection (HPLC–EC) consisting from a Jasco pump 
(PU1580, Tokyo, Japan) equipped with a DG-2080-54 four-line degasser, an AS 2057 Plus 
Automatic injector and connected to an Intro digital amperometric (Antec, Leyden, Zoeter-
woude, Netherlands) detector operated at Eox=+0.65 V with a sensitivity of 1-10 nA/V with 
a time filter of 1.0 sec, and JMBS Hercule 2000 Chromatography Interface (Le Fontanil, 
France). Standard temperature of the column was 25±0.15 °C.  
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Chromatograms were electronically stored and evaluated using Borwin 1.50 
Chromatography Software (JMBS, Le Fontanil, France). The separations were done using 
a Zorbax RX-C18 4.6x12.5 mm (5-µm) pre-column and a 4.6x250 mm, 5-µm Zorbax RX-
C18 octadecyl silica column (Agilent Technologies, supplied by Kromat Kft, Budapest, 
Hungary). For the serial determinations of the biogenic amines the mobile phase contained 
56.2 mmol/L Na2HPO4, 47.9 mmol/L citric acid, 0.027 mmol/L Na2EDTA, 0.925 mmol/L 
octane sulfonic acid sodium and 75:925 mL acetonitrile/phosphate buffer for hormonal 
imprinting oxytocin treatment and 65:935 mL acetonitrile/phosphate buffer for K-203 
treatment. The pH was adjusted to 3.7 with 85% phosphoric acid (H3PO4) (inoLab pH 
Level 2, WTW GmbH, Germany). The flow rate of the mobile phase was 1 mL/min. The 
limit of quantitation (LOQ) was determined at a signal to noise ratio of 10. The limit of 
detection (LOD) was determined at a signal to noise ratio of 3. 
 
3.2. Experimental animals 
During all the experiments, the guiding principles in the care of and use of laboratory 
animals have been observed. All experimental procedures conformed to 86/509/EEC 
regulation on the well-being of experimental animals, and the experimental protocol was 
approved by the local ethical committee (permission No: 1806/007/2004 ANTSZ, 
Budapest, Hungary). 
 
3.3. Treatments 
Treatments of rats with oxytocin for hormonal imrinting: Wistar rats of our (Charles River 
originated) closed breeding colony were housed at room temperature under normal light 
cycle and food and water were available ad libitum. Offsprings were treated 
subcutaneously (sc.) with a single dose of 5 mg/kg oxytocin (dissolved in saline) when 
they were one day old. When the off-spring were 4 months old, they were exsanguinated 
through the canthus under ether anesthesia and 8 regions of the brain (front cortex, FC; 
hypothalamus, HT; hippocampus, HC; striatum, ST; medulla oblongata, MO; cerebellum, 
CB; spinal cord, SC; and truncus cerebri, TC) were dissected on a 0 °C aluminum surface 
according to the method of Paxinos G. and Watson C. (1998) and Palkovits M. (2001). The 
samples were kept frozen at - ︎ 80︎  °C.  
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Treatments of rats with K-203: Rats were injected in 0.2 mL volume intramuscularly (i.m) 
with 50 µmol of K-203 freshly dissolved in distilled water. The control group received an 
equal volume (0.2 mL) of solvent treatment. Five rats were used for each data point. Rats 
were sacrificed by decapitation 15 or 60 min following treatment. Seven regions of the 
brain (FC, HT, HC, ST, MO, CB and SC) were dissected and immediately placed on an 
ice-cold aluminum surface according to the method of Paxinos G. and Watson C. (1998) 
and Palkovits M. (2001). All samples were kept frozen at -80 °C. 
3.3. Sample preparation 
 
Sample preparation in the oxytocin-experiment: The brain samples were homogenized in 5 
volumes of 0.8 mol/L ice cold perchroric acid (PCA) and serum samples were 
homogenized in 10 volumes of 0.8 mol/L PCA by an Ultra Turrax T25 Janke&Kunkel 
homogenizer at 20,000 rpm for 20 seconds (IKA Labortechnik, Staufen, Germany), then 
the brain samples were centrifuged in an Eppendorf centrifuge (A. Hettich, Tuttlingen, 
Germany) at 14,000 rpm for 10 min at 4 ◦C and the serum samples for 20 min at 4 ◦C. The 
supernatants gained were used for HPLC analysis. The samples were injected in 50 µL into 
the HPLC. Samples were kept at -80 ◦C before their analysis.  
Sample preparation in the K-203-experiment: Brain samples were homogenized in 4 
volumes of 0.8 mol/L ice cold PCA by an Ultra Turrax T25 Janke&Kunkel homogenizer at 
20,000 rpm for 20 seconds and after centrifuged in an Eppendorf centrifuge at 14,000 rpm 
for 10 min at 4 °C and the supernatants were used for HPLC analysis.  The samples were 
injected in 50 µL into the HPLC. Samples were kept at -80 °C before their analysis. 
 
4. Results 
4.1. Oxytocin hormonal imprinting measurement 
Norepinephrine (NA): There is a significant difference in norepinephrin tissue levels 
between the control males and females in case of the blood serum, hippocampus, and 
frontal cortex in favour of the females. Oxytocin-treated male samples contain higher 
norepinephrine neurotransmitter levels in the frontal cortex and cerebellum, while there is 
a decrease in the medulla oblongata. 
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Epinephrine: There is no significant difference in epinephrine tissue levels in the blood 
serum and different parts of brain region (hypothalamus; medulla oblongata; striatum) 
between the control and oxytocin-treated animals. 
Dopamine (DA): There is a significant difference between the male and female blood 
serum dopamine content in favour of males. Treated males serum contains significantly 
less dopamine, then the control ones. However significantly elevated dopamine level is 
present in the frontal cortex in oxytocin-treated females. 
DOPAC (3, 4-Dihydroxyphenyl acetic acid): There is a significant difference between 
the male and female DOPAC content in the hypothalamus in favor of males. Less DOPAC 
was found in male and female serum, hypothalamus, spinal cord, male striatum, and 
female truncus oxytocin-treated rats compared to the control ones 
HVA (homovanillic acid): There is a significant difference in homovanillic acid tissue 
levels between the control and oxytocin-treated animal serum, male hippocampus, 
hypothalamus, striatum, and truncus. Control female truncus contains less homovanillic 
acid, than control male 
5-HIAA (5-hydroxyindole acetic acid): There is a significant difference in 5-HIAA tissue 
levels between the male and female control sera in favor of females. Oxytocin-treated male 
5-HIAA values are less in hippocampus, hypothalamus, spinal cord and striatum as well as 
in female serum, hypothalamus, and medulla oblongata. The female serum value is higher 
than male in the controls. 
5-HTOL (5-hydroxytryptophol): There is a significant decrease in 5-HTOL, tissue level 
in the hypothalamus in both males and females in control and oxytocin-treated animals and 
a lower level 5-HTOL in the male oxytocin-treated in medulla oblongata 
Serotonin (5-HT): There is a significant difference in the serotonin tissue levels between 
the oxytocin-treated male and female sera in favor of females. In the hypothalamus and the 
striatum of females, the serotonin tissue level was higher than the female control values. 
Figure 1 show the representative chromatograms of biogenic amines (DA and 5-HT) and 
their metabolites (DOPAC, HVA and 5-HIAA) determinations from the oxytocin 
hormonal imprinted rat brain and serum.  
Table 1, Summarized data on the effect of oxytocin hormonal imprinting on biogenic 
amines and their metabolites level: 
	   8	  
Biogenic 
Amine 
 
Serum 
 
HC HT MO SC FC CB ST TC 
              m 
DA 
                 f 
↓ 
 
ns 
nda 
 
nda 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
↑ 
nda 
 
nda 
ns 
 
ns 
ns 
 
↓ 
                m 
DOPAC 
                 f 
↓ 
 
↓ 
ns 
 
ns 
 
↓ 
 
↓ 
ns 
 
ns 
 
↓ 
 
↓ 
ns 
 
ns 
 
nda 
 
nda 
 
↓ 
 
ns 
 
ns 
 
↓ 
 
                m 
HVA 
                 f 
↓ 
 
↓ 
↓ 
 
ns 
↓ 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
↓ 
 
ns 
 
↓ 
 
ns 
 
                m 
5-HIAA 
                 f 
↑ 
 
↓ 
↓ 
 
ns 
 
↓ 
 
↓ 
 
ns 
 
↓ 
 
↓ 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
↓ 
 
ns 
 
ns 
 
ns 
 
                m 
5-HTOL 
                 f 
nda 
 
nda 
 
ns 
 
ns 
 
↓ 
 
↓ 
↓ 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
nda 
 
nda 
 
nda 
 
nda 
 
ns 
 
ns 
 
                m 
5-HT 
                 f 
ns 
 
↑ 
nda 
 
nda 
 
ns 
 
↑ 
ns 
 
ns 
 
ns 
 
ns 
 
nda 
 
nda 
 
nda 
 
nda 
 
ns 
 
↑ 
ns 
 
ns 
 
                m 
NA 
                 f 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
↓ 
 
ns 
 
ns 
 
ns 
 
↑ 
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ns 
 
ns 
 
ns 
 
ns 
 
ns 
 
Table 1. Effect of oxytocin hormonal imprinting on biogenic amines and their metabolites level, 
Abbreviations: f - female, m - male, ↑- significant (p< 0.05) increase, ↓- significant (p< 0.05) decrease, ns – 
no significant change, nda – no data available.	  Hippocampus, HC; hypothalamus, HT; medulla oblongata, 
MO; spinal cord, SC; frontal cortex, FC; cerebellum, CB; striatum, ST; truncus cerebri, TC. 
 
                                  (A)                                                                                         (B)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	    
Figure 1. Representative chromatograms of biogenic amines and their metabolites (1: DOPAC; 2: 
dopamine; 3: 5-HIAA; 4: HVA and 5: 5-HT) tissue level from the rat brain (A) and serum (B) (upper 
chromatogram: control animal, on middle chromatogram: spiked and on bottom chromatogram: 
oxytocin treated rats).  
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4.2. K-203 treated rats  
Figure 2 show the representative chromatograms of biogenic amines (DA and 5-HT) and 
their metabolites (DOPAC, HVA and 5-HIAA) tissue levels that were obtained from the 
K-203 treated rats brain, Cerebrospinal fluid (CSF) and serum. 
                    (A)                                            (B)                                             (C) 
 
 
Figure 2. Representative chromatograms of biogenic amines and their metabolites (1: DOPAC; 2: 
dopamine; 3: 5-HIAA; 4: HVA and 5: 5-HT) tissue level from the rat brain (A), CSF (B) and serum 
(C) (upper chromatogram: control animal, on middle chromatogram: spiked and on bottom 
chromatogram: K-203 treated rats).  
 
                           (A)                                              (B)                                     (C) 
 
Figure 3. Representative chromatogram of serotonin (SER) and 5-HIAA levels in the spinal cord 
sample following 15  (A) and 60 min (B) and dopamine level in the striatum sample of rat following 60 
min (C) of K-203 (50-µmol, i.m) treatment. 
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Table 2 summarizes biogenic amines (DA and 5-HT) and their metabolites (HVA and 5-
HIAA) tissue levels in the different brain areas (FC, HT, HC, ST, MO, CB and SC) studied 
15 and 60 min following 50-µmol intramuscular K-203 injections.    
 
 
 
 
 
 
Table 2. Effect of K-203 on the biogenic amine and their metabolites tissue levels in rat brain areas. 
Each value represents data from five animals (n=5). (Hashemi et al. 2013) 
 
As serotonin and 5-HIAA tissue levels showed a consistent changing tendency, we 
calculated the 5-HIAA/5-HT ratios (known as a measure for turnover) in all the brain areas 
(Table 3). 
 
Tissue level 
Rat brain area  5-HT (ng/g ± SD) 
5-HIAA 
(ng/g± SD) 
DA 
(ng/g± SD) 
 
HVA 
(ng/g± SD) 
 
Cerebellum 
     Control 
     K203 
            15 min 
            60 min 
 
21.33±4.24 
 
42.82±11.0 
24.62±6.87 
 
114.1±8.97 
 
125.1±11.1 
197.0±26.7 
 
16.23±0.62 
 
17.43±1.09 
16.16±1.55 
 
< LOQ(1ng/g) 
 
Spinal cord 
     Control 
      K203 
            15 min 
            60 min 
 
489.4±70.8 
 
620.9±31.4 
440.1±11.1 
 
342.7±19.5 
 
358.1±24.4 
426.2±62.1 
 
30.03±4.88 
 
36.07±4.28 
33.85±2.35 
 
< LOQ(1ng/g) 
 
Hippocampus 
      Control 
      K203 
            15 min 
            60 min 
 
32.17±5.65 
 
52.08±8.55 
37.50±10.4 
 
170.4±34.3 
 
177.1±10.8 
186.5±7.60 
 
13.04±0.31 
 
14.07±0.82 
14.11±0.94 
 
< LOQ(1ng/g) 
 
Hypothalamus 
      Control 
      K203 
            15 min 
            60 min 
 
108.2±10.3 
 
170.9±35.7 
132.8±37.4 
 
263.0±64.1 
 
265.7±19.5 
260.0±50.6 
 
65.24±8.52 
 
91.98±28.5 
63.34±26.7 
 
< LOQ(1ng/g) 
 
Striatum      
      Control 
      K203 
            15 min 
            60 min 
 
61.64±23.2 
 
86.47±14.0 
70.79±27.4 
 
173.3±39.3 
 
179.9±12.9 
193.6±9.77 
 
1493±529 
 
1844±136 
1683±413 
 
285.9±69.3 
 
220.0±17.0 
277.8±59.6 
Medulla oblongata 
      Control 
      K203 
            15 min 
            60 min 
 
 
145.5±22.3 
 
167.1±29.5 
121.0±35.1 
 
 
201.8±53.42 
 
194.6±29.4 
184.2±38.7 
 
 
22.25±2.56 
 
24.68±4.36 
21.76±3.15 
 
 
< LOQ(1ng/g) 
 
Frontal cortex 
      Control 
      K203 
            15 min 
            60 min 
 
22.46±9.04 
 
51.71±15.6 
52.59±37.7 
 
154.2±23.5 
 
146.4±5.57 
155.0±17.8 
 
15.56±1.36 
 
16.83±1.83 
23.48±19.1 
 
< LOQ(1ng/g) 
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5-HIAA/5-HT (mean ±  SD) 
 
 
Rat brain area Control 15 min 60 min 
 
P-value 
 
Cerebellum 
 
11.26 ± 4.20 
 
4.73 ± 1.73* 
 
10.36 ± 4.23 
 
0.015 
Spinal cord 
 
0.84 ± 0.22 
 
0.70 ± 0.05 
 
0.97 ± 0.26 
 
0.206 
Hippocampus 
 
9.08 ± 3.73 
 
  4.90 ± 0.69* 
 
8.37 ± 2.94 
 
0.040 
Hypothalamus 
 
3.13 ± 0.74 
 
2.05 ± 0.67* 
 
2.60 ± 0.56 
 
0.043 
Striatum 
 
4.39 ± 2.04 
 
2.79 ± 0.43 
 
4.39 ± 2.09 
 
0.126 
Medulla oblongata 
 
1.78 ± 0.58 
 
1.47 ± 0.16 
 
2.44 ± 1.38 
 
0.238 
Frontal cortex 
 
12.09 ± 6.16 
 
3.57 ± 0.63* 
 
4.41 ± 1.77+ 
 
* 0.036 
+ 0.031 
Table 3. Serotonin turnover in rat brain areas following K-203 50-µmol i.m administration. The P< 
0.05 was considered significantly different. *: compared to control; +: compared to 15 min value. Each value 
represents data from five animals (n=5). (Hashemi et al. 2013) 
4.3. Calibration curve determination 
 
The calibration sequences from stock solutions (100 µg/mL) were prepared at a 
concentration of at least 8 and measurements were replicated 3 times in the range of 2-200 
ng/mL for oxytocin hormonal imprinting experiment and in the range of 10-200 ng/mL for 
K-203 experiment. Solvent used in the sample preparation was 0.8 M PCA solution and for 
spiked chromatograms the supernatant originating from the brain and serum samples 
gained from vehicle-treated controls were used. From all the areas of the peaks as a 
function of concentration the least squares method (Microsoft Excell 2003) was used. 
Calibration curves for all noradrenaline, adrenaline, DA, DOPAC, 5-HIAA, HVA, 5-HT, 
and 5-HTOL were linear.  
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5. Conclusion 
 
The following conclusions may be drown from the present research work: 
 
>> The developed and optimized RP-HPLC method using electrochemical (EC) detection 
is a valuable bioanalytical method to determine biogenic amines and their metabolites from 
different rat brain areas following neonatal oxytocin hormonal imprinting and a single dose 
of K-203 treatment. 
 
>> The single dose of 5 mg/kg oxytocin treatment (hormonal imprinting) of neonates, after 
4 months, strongly, permanently and in brain region specific manner influenced the adult 
level of biogenic amines (noradrenaline, adrenaline, dopamine and 5-HT) and their 
metabolites (DOPAC, 5-HIAA, HVA and 5-HTOL). The hypothalamus and striatum are 
the most sensitive to the effect of neonatal oxytocin imprinting. 	  >>	  Oxytocin is a strong imprinter, which interacts with the brain dopamine and serotonin 
systems influencing emotional and social behavior. Our data may indicate impact of 
oxytocin on the development of such diseases, as autism spectrum disorder. Considering 
the strong and late manifesting effect of hormonal imprinting, the single oxytocin 
treatment of neonates may explain the symptoms that are characteristic to diseases.  
 
>> Studying the effect of K-203, a potential antidote in organophosphate poisoning on the 
biogenic amines and their metabolites levels in seven brain areas of rat in a dose (50-µmol) 
and by the proposed type of administration (i.m) it can be concluded, that K-203 is a safe 
potential antidote. Its effect on the 5-HT and dopamine metabolism is brain-area specific 
and transient.  In line with literature data it can be summarized, that K-203 has much 
higher antidotal effectiveness than any other pyridinium aldoximes used hitherto and 
milder side effects than other pyridinium aldoximes. 
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6. Summary 
 
1. Oxytocin is a mammalian neurohypophysial hormone and has role in various behaviors, 
including numerous central nervous system functions such as sexual, maternal behaviour, 
social recognition, anxiety, memory, learning, stress and social behaviors. Most of 
oxytocin’s roles are due to the cooperation with biogenic amines in different brain regions. 
Our results show that the single dose of 5mg/kg oxytocin treatment to rat neonates has a 
significant hormonal imprinting effect resulting in strongly and permanently influenced 
adult level of biogenic amines in different brain regions.  
The hypothalamus is the most sensitive to imprinting followed by striatum. 
Literature data unanimously show that there are diseases that are in close connection with 
the metabolism of dopamine and serotonin in the hypothalamus and striatum (Parkinson 
disease, autism, schizophrenia), and aggressive behavior is influenced by brain serotonin 
metabolism. It is supposed that oxytocin is a key molecule, which interacts with the brain 
dopamine and serotonin system, therefore it can be established that perinatal oxytocin 
treatment seems to be a serious factor. 
 
2. As organophosphate poisoning is a constant danger and the therapeutic usefulness of 
currently available antidotes is low and is still a matter of controversy. There is a 
permenant need for more effective broad-spectrum antidotes. K-203 is a newly synthesized 
bispyridinium monoaldoxime type antidote with low toxicity and superior in vitro potency 
for use in organophosphate poisoning, especially in the case of tabun-poisoned. 
Measuring the effect of K-203 on the biogenic amines and their metabolites in the different 
brain areas of the rat brain in a dose (50-µmol) and by the proposed type of administration 
(i.m) we can conclude that the effect of K-203 on the 5-HT and dopamine metabolism is 
brain-area specific and transient. The K-203 can be evaluated as an effective and safe 
antidote in organophosphate intoxication with effective acetylcholine-esterase reactivator 
activity. 
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6.1. Összefoglalás 
1. Az oxytocin, mint a neurohipofízis nonapeptid hormonja emlősökben számos 
viselkedési forma (nemi funkciók, anyai gondoskodás, a fajtársak felismerése, félelmi 
reakciók, memória, tanulási képesség, stressz-válasz, társas kapcsolatok) központi 
idegrendszeri szabályozásában is fontos szerepet játszik.Ezek a sokrétű hatások döntően a 
biogénaminok anyagcseréjének befolyásolása útján valósulnak meg. Vizsgálatainkban 
kimutattuk, hogy újszülött patkányok egyszeri 5 mg/kg oxytocinnal történő kezelése 
jelentős hormonális „imprinting” hatású, mellyel tartós és jelentős valamint régiószelektív 
változást okoz a felnőttkori  agyi biogénamin anyagcserében. A hormonális imprintig a 
nyolc vizsgált agyterület közül legerőteljesebben a hypothalamus és a striatum dopamin és 
szerotonin anyagcseréjét befolyásolja. Irodalmi adatok egyértelműen bizonyítják, hogy a 
hypothalamus és a striatum dopamin és szerotonin anyagcseréjének zavarával 
jellemezhetőek olyan betegségek, mint pl. a Parkinson kór, autizmus, skizofrénia valamint 
a szerotonin anyagcsere zavara fontos szereppel bír az aggressziv viselkedésforma 
létrejöttében. A kísérletes adatok tükrében az oxytocin kulcsszerepet játszik a dopamin és a 
szerotonin anyagcsere szabályozásában, ezért perinatális oxytocin-kezelés esetén súlyos 
következményekkel lehet számolni. 
2. Az organofoszfátokkal történő véletlen és szándékos mérgezések súlyossága és 
gyakorisága valamint a klinikai gyakorlatban hozzáférhető antidótumok csekély terápiás 
értéke miatt az új, nagyhatékonyságú és az organofoszfátok széles skálájával szemben is 
alkalmazható acetilkolineszteráz- reaktivátor antidótumok kutatása nagy erőkkel folyik. A 
többszáz közelmúltban szintetizált vegyület közül a bispyridinium monoaldoxim 
szerkezetű  K-203 kiemelkedő in vitro hatékonyságot mutat különösen tabun-mérgezéssel 
szemben és csekély önálló toxicitású. Kimutattuk, hogy a K-203 további előnyös 
tulajdonságai közé tartozik az is, hogy terápiásan hatékony mennyiségben bejut a központi 
idegrendszerbe is. Vizsgálatainkban a terápiás alkalmazást modellezve (50-µmol, i.m.) 
megállapítottuk, hogy a K-203 a központi idegrendszeri dopamin és szerotonin 
anyagcserére csak átmeneti és gyenge hatást fejt ki. A K-203 vizsgálataink tükrében egy 
igen hatékony és biztonságos acetilkolineszteráz reaktiváló antidótumnak minősül 
organofoszfátok okozta mérgezés esetén. 
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